These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17934334)

  • 21. Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways.
    Su Y; Wan D; Song W
    Anticancer Drugs; 2016 Aug; 27(7):660-8. PubMed ID: 27243922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of periostin gene expression via RNA interference suppressed the proliferation, apoptosis and invasion in U2OS cells.
    Liu C; Huang SJ; Qin ZL
    Chin Med J (Engl); 2010 Dec; 123(24):3677-83. PubMed ID: 22166650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
    Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9.
    Kim SM; Lee H; Park YS; Lee Y; Seo SW
    J Orthop Res; 2012 Jul; 30(7):1040-4. PubMed ID: 22213073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risedronate inhibits human osteosarcoma cell invasion.
    Xin ZF; Kim YK; Jung ST
    J Exp Clin Cancer Res; 2009 Jul; 28(1):105. PubMed ID: 19624845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM
    Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.
    Zhang Y; Wei RX; Zhu XB; Cai L; Jin W; Hu H
    Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44.
    Kinugasa Y; Hatori M; Ito H; Kurihara Y; Ito D; Nagumo M
    Clin Exp Metastasis; 2004; 21(8):737-45. PubMed ID: 16035618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
    Nystrom ML; McCulloch D; Weinreb PH; Violette SM; Speight PM; Marshall JF; Hart IR; Thomas GJ
    Cancer Res; 2006 Nov; 66(22):10833-42. PubMed ID: 17108119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress induced by low-dose doxorubicin promotes the invasiveness of osteosarcoma cell line U2OS in vitro.
    Shin SH; Choi YJ; Lee H; Kim HS; Seo SW
    Tumour Biol; 2016 Feb; 37(2):1591-8. PubMed ID: 26298721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione Peroxidase 2 Inhibits Cyclooxygenase-2-Mediated Migration and Invasion of HT-29 Adenocarcinoma Cells but Supports Their Growth as Tumors in Nude Mice.
    Banning A; Kipp A; Schmitmeier S; Löwinger M; Florian S; Krehl S; Thalmann S; Thierbach R; Steinberg P; Brigelius-Flohé R
    Cancer Res; 2008 Dec; 68(23):9746-53. PubMed ID: 19047153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
    Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells.
    Onoda T; Ono T; Dhar DK; Yamanoi A; Fujii T; Nagasue N
    J Lab Clin Med; 2004 Apr; 143(4):207-16. PubMed ID: 15085079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.